Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–13.
Article PubMed PubMed Central Google Scholar
Chun BY, Dobson AJ, Heller RF. The impact of diabetes on survival among patients with first myocardial infarction. Diabetes Care. 1997;20(5):704–8.
Article CAS PubMed Google Scholar
Gustafsson I, Hildebrandt P, Seibaek M, et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J. 2000;21(23):1937–43.
Article CAS PubMed Google Scholar
Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction Register Study Group. Diabetes Care. 1998;21(1):69–75.
Article CAS PubMed Google Scholar
Alabas OA, Hall M, Dondo TB, et al. Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. J Epidemiol Community Health. 2017;71(1):25–32.
Article CAS PubMed Google Scholar
Eliasson M, Jansson JH, Lundblad D, Näslund U. The disparity between long-term survival in patients with and without diabetes following a first myocardial infarction did not change between 1989 and 2006: an analysis of 6,776 patients in the Northern Sweden MONICA Study. Diabetologia. 2011;54(10):2538–43.
Article CAS PubMed Google Scholar
Winell KM, Pääkkönen R, Pietilä A, Niemi MK, Reunanen AR, Salomaa VV. Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend. Diabetologia. 2010;53(3):472–80.
Article CAS PubMed Google Scholar
Ahmed B, Davis HT, Laskey WK. In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000–2010. J Am Heart Assoc 2014;3(4).
Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke statistics: a report of US and Global Data from the American Heart Association. Circulation. 2024;149(8):e347–913.
American Diabetes Association Professional Practice C. 9. Pharmacologic approaches to Glycemic Treatment: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S158–78.
American Diabetes Association Professional Practice C. 7. Diabetes Technology: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S126–S144.
American Diabetes Association Professional Practice C. 10. Cardiovascular Disease and Risk Management: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S179–218.
Kerola AM, Palomäki A, Rautava P, Kytö V. Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction. Eur J Prev Cardiol. 2022;29(10):1437–45.
Prami T, Khanfir H, Deleskog A, et al. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland. BMJ Open. 2016;6(11):e012604.
Article PubMed PubMed Central Google Scholar
Kerola AM, Juonala M, Palomäki A, Semb AG, Rautava P, Kytö V. Case fatality of patients with type 1 diabetes after myocardial infarction. Diabetes Care. 2022;45(7):1657–65.
Article CAS PubMed PubMed Central Google Scholar
Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12(2):132–7.
Palomäki A, Kerola AM, Malmberg M, Rautava P, Kytö V. Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study. Rheumatology (Oxford). 2021;60(11):5205–15.
Kerola AM, Semb AG, Juonala M, Palomäki A, Rautava P, Kytö V. Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction. Cardiovasc Diabetol. 2022;21(1):177.
Article PubMed PubMed Central Google Scholar
Kytö V, Sipilä J, Ahtela E, Rautava P, Gunn J. Mechanical Versus Biologic prostheses for Surgical aortic valve replacement in patients aged 50 to 70. Ann Thorac Surg. 2020;110(1):102–10.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med. 2017;167(4):268–74.
Koek HL, Soedamah-Muthu SS, Kardaun JW, et al. Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol. 2007;22(12):883–8.
Article CAS PubMed PubMed Central Google Scholar
Löwel H, Köenig W, Engel S, Hormann A, Keil U. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia. 2000;43(2):218–26.
Norhammar A, Lindbäck J, Ryden L, et al. Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart. 2007;93(12):1577–83.
Article PubMed PubMed Central Google Scholar
Nedkoff L, Knuiman M, Hung J, Briffa TG. Improving 30-day case fatality after incident myocardial infarction in people with diabetes between 1998 and 2010. Heart. 2015;101(16):1318–24.
Article CAS PubMed Google Scholar
Nauta ST, Deckers JW, Akkerhuis KM, van Domburg RT. Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008. Diabetes Care. 2012;35(10):2043–7.
Article PubMed PubMed Central Google Scholar
Patel PA, Cubbon RM, Sapsford RJ, et al. An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction. Int J Cardiol. 2016;203:141–4.
Gruppetta M, Calleja N, Fava S. Long-term survival after acute myocardial infarction and relation to type 2 diabetes and other risk factors. Clin Cardiol. 2010;33(7):424–9.
Article PubMed PubMed Central Google Scholar
Matetic A, Doolub G, Bharadwaj A, et al. Differential Impact of Type 1 and type 2 diabetes Mellitus on outcomes among 1.4 million US patients undergoing percutaneous coronary intervention. Cardiovasc Revasc Med. 2022;38:83–8.
Fojt A, Kowalik R, Gierlotka M, Gasior M, Smeding C, Opolski G. Three-year mortality after acute myocardial infarction in patients with different diabetic status. Pol Arch Intern Med 2021;131(11).
Baviera M, Genovese S, Colacioppo P, et al. Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction. Cardiovasc Diabetol. 2022;21(1):223.
Article PubMed PubMed Central Google Scholar
Nedkoff L, Knuiman M, Hung J, Briffa TG. Long-term all-cause and cardiovascular mortality following incident myocardial infarction in men and women with and without diabetes: temporal trends from 1998 to 2009. Eur J Prev Cardiol. 2016;23(12):1273–81.
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.
Article CAS PubMed Google Scholar
Roger VL, Weston SA, Gerber Y, et al. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010;121(7):863–9.
Article PubMed PubMed Central Google Scholar
Marenzi G, Cosentino N, Genovese S, et al. Reduced cardio-renal function accounts for most of the In-Hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-Segment Elevation myocardial infarction. Diabetes Care. 2019;42(7):1305–11.
Brener SJ, Mehran R, Dressler O, Cristea E, Stone GW. Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). Am J Cardiol. 2012;109(8):1111–6.
留言 (0)